Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MD PhD, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Wan X. Hong, MD, Rachel Greenstein, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 2825.

https://doi.org/10.1182/blood-2019-129661

Published: 2019

Journal Articles

Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy

Karen Chau, BA, Brandon Imber, MD MA, Erel Joffe, MDMSc, Joanna C. Yang, MD, Monica Chelius, BS, Connor Doyle, Carla Hajj, MD, Joachim Yahalom, MD

Blood (2019) 134 (Supplement_1): 2827.

https://doi.org/10.1182/blood-2019-132275

Published: 2019

Journal Articles

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Samantha Brocklehurst, Neil Desai, MD MHS, Jennifer L Shah, MD, Syed Rizvi, MD, Praveen Ramakrishnan Geethakumari, MD, Kiran A Kumar, MD MBA

Blood (2019) 134 (Supplement_1): 5262.

https://doi.org/10.1182/blood-2019-131246

Published: 2019

Journal Articles

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Tanaya Shree, MD PhD, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 1479.

https://doi.org/10.1182/blood-2019-131684

Published: 2019

Journal Articles

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Tanaya Shree, MD PhD BA, Anuja Sathe, PhD, Debra K. Czerwinski, BA, Steven R. Long, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 4107.

https://doi.org/10.1182/blood-2018-99-119925

Published: 2018

Journal Articles

Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma

Blood (2018) 132 (Supplement 1): 2892.

https://doi.org/10.1182/blood-2018-99-117932

Published: 2018

Journal Articles

Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/ 2 Study Examining G100 Alone and in Combination with Pembrolizumab

Blood (2017) 130 (Supplement 1): 2771.

https://doi.org/10.1182/blood.V130.Suppl_1.2771.2771

Published: 2017

Journal Articles

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

Sung Yong Oh, Jin Seok Kim, MD PhD, Ji Hyun Lee, MD PhD, Won Seog Kim, MD, Ph. D., Seok Jin Kim, MD PhD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Won-Sik Lee, MD, Hyo Jung Kim, MD PhD, Jong-Ho Won, MD, Byeong Park, MD, Soon Il Lee, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5155.

https://doi.org/10.1182/blood.V130.Suppl_1.5155.5155

Published: 2017

Journal Articles

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Ronald Levy, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD, Nancy L Bartlett, MD, Leo I. Gordon, MD, Abraham Leung, MD, Joanna Peterkin, MD MS, Biao Xing, Robert Coffman, PhD, Robert Janssen, MD, Albert Candia, PhD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Steven R Long, MD, Debra K Czerwinski, Michael Chu, MD

Blood (2016) 128 (22): 2974.

https://doi.org/10.1182/blood.V128.22.2974.2974

Published: 2016

Journal Articles

Repetitive Low-Dose Radiation Therapies As an Alternative Option for Indolent Non-Hodgkin Lymphoma

Khalil Saleh, MD, Jean-Marie Michot, MD, Alina Danu, MD, Julien Lazarovici, MD, Nadine Khalifé-Saleh, MD, David Ghez, PhD MD, Claude Chahine, MD, Yolla Dakdouki, MD, Jonathan Fahri, Resident, Christophe Willekens, MD, Angela Boros, MD, Julia Arfi-Rouche, MD, Pierre Maroun, MD, Eric Deutsch, PhD MD, Vincent Ribrag, MD, Renaud Mazeron, MD

Blood (2016) 128 (22): 1784.

https://doi.org/10.1182/blood.V128.22.1784.1784

Published: 2016

Journal Articles

Regulatory T Cells Are Depleted in Low-Grade Lymphoma By the Combination of Local Low-Dose Radiation Followed By Intratumoral CpG-ODN

Debra K Czerwinski, Steven R Long, MD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Michael P. Chu, MD, Ami Okada, PhD, Kathleen A McDonald, BA, Holbrook E Kohrt, MD PhD, Nancy L Bartlett, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD MMSc, Leo I. Gordon, MD, Robert Coffman, PhD, Robert Janssen, MD, Ronald Levy, MD

Blood (2015) 126 (23): 1539.

https://doi.org/10.1182/blood.V126.23.1539.1539

Published: 2015

Journal Articles

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Holbrook E Kohrt, MD PhD, Jaqueline Chu, MD, Joshua Brody, MD, Debra K Czerwinski, Cariad Chester, Mohith Sadaram, BS, Ranjana Advani, MD, Youn H. Kim, MD, Richard T. Hoppe, MD, Susan J. Knox, MD PhD, Irene Wapnir, MD, Robert J. Tibshirani, PhD, Ron Levy, MD

Blood (2014) 124 (21): 3092.

https://doi.org/10.1182/blood.V124.21.3092.3092

Published: 2014

Journal Articles

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Santosh L. Saraf, MD, Annie L. Oh, MD, Dolores Mahmud, PhD, Pritesh R. Patel, MB, ChB, Karen Sweiss, PharmD, Matthew Koshy, MD, Sally Campbell-Lee, MD, Michel Gowhari, DO, Johara Hassan, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Lewis L. Hsu, MD PhD, Nadim Mahmud, MD PhD, Dennis J Levinson, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2014) 124 (21): 2703.

https://doi.org/10.1182/blood.V124.21.2703.2703

Published: 2014

Journal Articles

Metastatic Breast Cancer in a Patient with Fanconi Anemia

Jeffrey Graham, MD, Debjani Grenier, MD, Arjuna Ponnampalam, MD

Blood (2014) 124 (21): 5164.

https://doi.org/10.1182/blood.V124.21.5164.5164

Published: 2014

Journal Articles

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Elizabeth M. Kang, MD, Harry Malech, MD, Dianne Hilligoss, Martha Marquesen, Corin Kelly, Mark Parta, MD

Blood (2013) 122 (21): 2157.

https://doi.org/10.1182/blood.V122.21.2157.2157

Published: 2013

Journal Articles

Low-Dose Radiotherapy in Patients with Non Hodgkin Lymphoma

Dulcineia Pereira, MD, Sergio Pereira Chacim, MD, Andre Soares, MD, Edgar Mesquita, MSc, Ana Espirito-Santo, MD, Ilidia Moreira, MD, Nelson Domingues, MD, Isabel Oliveira, MD, Luísa Viterbo, MD, Margarida Marques, MD, Rui Henrique, PhD, MD, Carla Castro, MD, Angelo Martins, MD, Angelo Oliveira, MD, Jose Mario Mariz, MD

Blood (2012) 120 (21): 4875.

https://doi.org/10.1182/blood.V120.21.4875.4875

Published: 2012

Journal Articles

The EOS ® System for the Detection of Bone Lesions in Patients with Multiple Myeloma,

Bastien Dutouquet, MD, Xavier Leleu, MD, PhD, Antoine Moraux, MD, Eileen Boyle, MD, Jordan Gauthier, MD, Houria Debarri, MD, Salomon Manier, MD, Marie Pierre Noel, MD, Thierry Facon, MD, Marie Helene Vieillard, MD, PhD, Anne Cotten, MD, Nathalie Boutry, MD, PhD

Blood (2011) 118 (21): 3921.

https://doi.org/10.1182/blood.V118.21.3921.3921

Published: 2011

Journal Articles

Hiatus in Infant Acute Leukemia Incidence rates in Belarus: Adaptation-to-Low-Dose-Radiation Phenomenon?

Vadim Ivanov, MD, PhD, Tatiana Terehovich, MD, PhD, Eugene Ivanov, MD, PhD

Blood (2011) 118 (21): 507.

https://doi.org/10.1182/blood.V118.21.507.507

Published: 2011

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Matthew M Hsieh, Courtney D Fitzhugh, MD, R. Patrick Weitzel, PhD, Wynona Coles, M Beth Link, John F. Tisdale

Blood (2011) 118 (21): 10.

https://doi.org/10.1182/blood.V118.21.10.10

Published: 2011

Journal Articles

Survival in Adolescents and Young Adults with Hodgkin Lymphoma Treated with Response-Based Chemotherapy on P9425 and P9426 Protocols: A Report From the Children's Oncology Group

Karen S. Fernández, MD, Lu Chen, PhD, Cindy Schwartz, MD, MPH, Allen R. Chauvenet, MD, PhD, Pedro A. de Alarcón, MD

Blood (2011) 118 (21): 91.

https://doi.org/10.1182/blood.V118.21.91.91

Published: 2011

NARROW

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma

Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/ 2 Study Examining G100 Alone and in Combination with Pembrolizumab

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Repetitive Low-Dose Radiation Therapies As an Alternative Option for Indolent Non-Hodgkin Lymphoma

Regulatory T Cells Are Depleted in Low-Grade Lymphoma By the Combination of Local Low-Dose Radiation Followed By Intratumoral CpG-ODN

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Metastatic Breast Cancer in a Patient with Fanconi Anemia

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Low-Dose Radiotherapy in Patients with Non Hodgkin Lymphoma

The EOS ® System for the Detection of Bone Lesions in Patients with Multiple Myeloma,

Hiatus in Infant Acute Leukemia Incidence rates in Belarus: Adaptation-to-Low-Dose-Radiation Phenomenon?

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Survival in Adolescents and Young Adults with Hodgkin Lymphoma Treated with Response-Based Chemotherapy on P9425 and P9426 Protocols: A Report From the Children's Oncology Group

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only